Executive Medical Director, Cell Therapy/Redirected Immunity, Oncology Clinical Science

Company: Takeda Pharmaceuticals International GmbH
Location: Cambridge
Posted on: April 5, 2021

Job Description:

*Please be aware of an Identity Theft Scheme targeting individuals seeking jobs with Takeda and other employers. See below or here for more info. Executive Medical Director, Cell Therapy/Redirected Immunity, Oncology Clinical Science Takeda fosters a collaborative and stimulating work environment filled with opportunity and the chance to make a difference in people's lives. It is a workplace driven by integrity, one of Takeda's long-held values that extends to both the patients we serve and our employees who develop and deliver medicines. Across our company, Takeda employees bring together diverse strengths that together create a stronger whole. As one of the world's leading biopharmaceutical companies, Takeda is committed to bringing Better Health and a Brighter future to people worldwide. We aspire to bring our leadership in translating science into life-changing medicines to the next level, in our core focus areas; oncology, gastroenterology, neuroscience, rare diseases, plasma-derived therapies, and vaccines. The Greater Boston Area is headquarters to many of our Global and US business units. We are a passionate team doing important work that impacts patients' lives. If you are driven to create better health and a brighter future, join us! Success What makes a successful member of our team? Check out the traits we're looking for and see if you have the right mix. Life at Takeda A Global Top Employer Recognized for our culture and way of working, we're one of only select companies to receive Top Global Employer -- status for 2021. Executive Medical Director, Cell Therapy/Redirected Immunity, Oncology Clinical Science Job ID R0024824 Date posted 11/10/2020 Location Boston, Massachusetts

• As leader of the Cell Therapy/Redirected Immunity strategy pillar within the Clinical Sciences function of Takeda Oncology, ensure that clinical development programs are appropriately designed to support Asset Strategy and OTAU objectives
• Partner with the Head, Oncology Cell Therapy Development, a new role established to evolve our R&D model for cell therapies while optimizing key internal and external interfaces.
• Partner with Oncology Drug Discovery Unite (ODDU) and Cell Therapy Translational Engine (CTTE) to provide clinical expertise and ensure clinical and preclinical asset development supports Cell Therapy Strategy and OTAU objectives
• Serve as the Subject Matter Expert (SME) at the synopsis and protocol review board (OTECH) for relevant studies
• Coordinate oncology-dedicated functional leaders across development as an extension of the TAU leadership team to enable advancement of the cell therapy/redirected immunity portfolio by the Global Program Teams (GPTs)
• Actively participate in business development assessments and in the governance of key Oncology partnerships related to the cell therapy/redirected immunity portfolio (e.g. JSC / JDC representative)
• Support the Head, Oncology Clinical Science in representing the OTAU at the Safety Board Leadership/People: Direct reports will include Global clinical leads (GCL) and study clinicians working on multiple cell therapy assets Geographic Scope: Global (OTAU) and Japan & Asia (OTAU J&A) ACCOUNTABILITIES.
  • Serve as a key Oncology strategist and thought partner to the Research, Development and Commercial oncology leaders bringing enterprise thinking, a strong external network, and state-of-the-art clinical knowledge to maximize the patient value of Takeda innovative Oncology portfolio.
  • Serve as an outstanding leader of the Clinical Sciences team who attracts, hires, motivates, challenges, and develops talents, with a focus on enhancing capabilities in cell therapy/redirected immunity.
  • As such, works closely with the Oncology leadership team to ensure optimal clinical science support of the oncology cell therapy portfolio including by Global Clinical Leads (GCLs).
  • As reference SME of the Oncology Tenjin Committee Hub (OTECH), work with oncology-designated global functional leaders and external advisors to provide cross-functional technical review of synopses and full protocols designed to implement the asset strategies.
  • Support the Chair of the Oncology Development Leadership Team (ODeLT), to facilitate execution by global project teams (GPTs) of portfolio review committed (PRC)-endorsed cell therapy plans, including taking ownership of issues escalated by GPTs, tackling portfolio-level operational challenges identified as major themes, and addressing strategic challenges beyond the scope of GPTs.
  • Support the Head, Oncology Clinical Science to manage the Oncology Clinical Science budget across regions.
  • Drive organizational team effectiveness initiatives that advance the fit-for-purpose Global Program Team model and Clinical SubTeam/Study Execution Team (CST/SET)
  • Drive key initiatives as a member of the Oncology TAU Leadership Team (OTAULT), including functional and cross-functional innovations in clinical development.
  • Serve as clinical development expert to the Oncology Business Unit and PRC stakeholders for cell therapy/redicted immunity program
  • Accountable for strategic medical guidance to Business Development.
  • Provide input and collaborate with (internal and external) cross-functional strategic teams and task forces. Technical/Functional (Line) Expertise
    • Has leading edge knowledge of principles, concepts, and theories in the discipline. May represent Company or act as an external technical resource.
    • Has relevant experience in the field of cell therapy and/or redirected immunity
    • Applies technical, line and business knowledge to lead the strategic direction of line and/or zone portfolio.
    • Develops innovative ideas and leads complex discipline, department and/or line projects. Leadership
      • Demonstrates strategic enterprise thinking, finding innovative ways to serve patients, and build trust, reputation and business
      • Creates the environment that inspires and enables people to collaborate and move the organization forward
      • Focuses on the few priorities and delivers superior results
      • Elevates the capabilities of the organization for now and the future Decision-making and Autonomy
        • Decisions have a long-term effect on the objectives of the Oncology TAU and on the Clinical Science function within Takeda R&D
        • Decisions impact the Clinical Science discipline and the Oncology TAU
        • Exercises foresight and judgment in initiating, planning, organizing and guiding highly complex projects across the clinical development lines.
        • Responsible for uncovering and resolving issues associated with the strategic development and implementation of operational programs. Advises colleagues on technical and policy issues; is considered a subject -matter expert providing technical guidance.
        • Contribution is evaluated based on business impact requiring a long-term perspective. Reviews work completed by other colleagues outside of direct line and/or from other teams. Interaction
          • Decisions have a long-term effect on the objectives of the discipline, department and/or line.
          • Decisions impact the discipline, department and/or line and its customers.
          • Influences the direction of the discipline to Company's advantage. Is a visionary in leveraging an environment of experimentation and developing creative thinking that will have an effect on Company, its partners, and the community. Complexity
            • Makes decisions by developing innovative options and/or multiple solutions to highly complex problems. Recommends courses of action to management and/or senior leaders that impact the discipline, department or line. Influences the decisions of management/senior leaders.
            • Provides/leads in-depth analyses and recommendations to management and senior leaders in complex ambiguous situations across the discipline, department and/or line. EDUCATION, BEHAVIOURAL COMPETENCIES AND SKILLS:
              • M.D. required. 15+ years related work experience.--
              • It is also required that this individual not only have sufficient grounding in the principles of the scientific method and cancer biology, but also have experience in oncology drug development and regulatory sciences sufficient to lead internal and external projects relevant to the Oncology TAU across the spectrum of R and D (early and late phase, LCM).--
              • Direct experience with executing development plans with cell therapies and/or redirected immunity approaches Check out where you could be
                working if you apply. Job Seekers: Protect yourself against identity theft Please be aware there are instances of identity thieves posting Takeda-branded jobs and posing as employees to steal personal information. They visit job-related websites and invite candidates to online chats. During the chat, they press job seekers to provide bank account information and Social Security numbers. Copyright 1995-2019 Takeda Pharmaceutical Company Limited. All rights reserved.

Keywords: Takeda Pharmaceuticals International GmbH, Cambridge , Executive Medical Director, Cell Therapy/Redirected Immunity, Oncology Clinical Science, Executive , Cambridge, Massachusetts